Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (61-70 of 332) with videos related to

Pageof 34
Sort By:
The Journal of Urology|June 23, 2009
Re: Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. A. A. Thomas, B. I. Rini, B. R. Lane, J. Garcia, R. Dreicer, E. A. Klein, A. C. Novick And S. C. Campbell. J Urol 2009; 181: 518-523Astrid A M van der Veldt, Epie Boven, Axel Bex
European Urology|September 2, 2018
Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell CarcinomaMichael Staehler, Dena Battle, Axel Bex, et al.
Current Opinion in Urology|December 3, 2019
Cytoreductive nephrectomy: does CARMENA (Cancer du Rein Metastatique Nephrectomie et Antiangiogéniques) change everything?Michael Grant, Bernadett Szabados, Teele Kuusk, et al.
European Urology Oncology|August 14, 2025
Reply to Hatice Bolek's Letter to the Editor re: Hilin Yildirim, Katja K.H. Aben, Maarten J. Bijlsma, et al. A Nationwide Real-world Evaluation of Upfront Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma in the Immunotherapy Era. Eur Urol Oncol 2025;8:623-31Hilin Yildirim, Adriaan D Bins, Axel Bex, et al.
European Urology|May 10, 2016
Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73Lorenzo Marconi, Thomas B Lam, Axel Bex, et al.
Current Opinion in Urology|March 20, 2021
Perioperative therapy in renal cancer in the era of immune checkpoint inhibitor therapyTeele Kuusk, Yasmin Abu-Ghanem, Faiz Mumtaz, et al.
European Urology Open Science|May 31, 2022
Outcomes for Atypical Tumor Recurrences Following Minimally Invasive Kidney Cancer OperationsPaul Russo, Kyle A Blum, Stanley Weng, et al.
Therapeutic Advances in Medical Oncology|October 22, 2019
Cytoreductive nephrectomy in the current treatment algorithmTeele Kuusk, Bernadett Szabados, Wing Kin Liu, et al.
Urology|February 19, 2017
Long-term Survival After Resection of Sentinel Node Metastatic Renal Cell CarcinomaTeele Kuusk, Jeroen De Jong, Nikolaos Grivas, et al.
World Journal of Urology|July 9, 2008
Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladderAxel Bex, Remco de Vries, Floris Pos, et al.
Pageof 34

Showing results (61-70 of 332) with videos related to

Sort By:
Pageof 34
The Journal of Urology|June 23, 2009
Re: Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. A. A. Thomas, B. I. Rini, B. R. Lane, J. Garcia, R. Dreicer, E. A. Klein, A. C. Novick And S. C. Campbell. J Urol 2009; 181: 518-523Astrid A M van der Veldt, Epie Boven, Axel Bex
European Urology|September 2, 2018
Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell CarcinomaMichael Staehler, Dena Battle, Axel Bex, et al.
Current Opinion in Urology|December 3, 2019
Cytoreductive nephrectomy: does CARMENA (Cancer du Rein Metastatique Nephrectomie et Antiangiogéniques) change everything?Michael Grant, Bernadett Szabados, Teele Kuusk, et al.
European Urology Oncology|August 14, 2025
Reply to Hatice Bolek's Letter to the Editor re: Hilin Yildirim, Katja K.H. Aben, Maarten J. Bijlsma, et al. A Nationwide Real-world Evaluation of Upfront Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma in the Immunotherapy Era. Eur Urol Oncol 2025;8:623-31Hilin Yildirim, Adriaan D Bins, Axel Bex, et al.
European Urology|May 10, 2016
Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73Lorenzo Marconi, Thomas B Lam, Axel Bex, et al.
Current Opinion in Urology|March 20, 2021
Perioperative therapy in renal cancer in the era of immune checkpoint inhibitor therapyTeele Kuusk, Yasmin Abu-Ghanem, Faiz Mumtaz, et al.
European Urology Open Science|May 31, 2022
Outcomes for Atypical Tumor Recurrences Following Minimally Invasive Kidney Cancer OperationsPaul Russo, Kyle A Blum, Stanley Weng, et al.
Therapeutic Advances in Medical Oncology|October 22, 2019
Cytoreductive nephrectomy in the current treatment algorithmTeele Kuusk, Bernadett Szabados, Wing Kin Liu, et al.
Urology|February 19, 2017
Long-term Survival After Resection of Sentinel Node Metastatic Renal Cell CarcinomaTeele Kuusk, Jeroen De Jong, Nikolaos Grivas, et al.
World Journal of Urology|July 9, 2008
Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladderAxel Bex, Remco de Vries, Floris Pos, et al.
Pageof 34